Delfa
Also known as: Delfa AI, delfa.ai
AI agents that automate clinical trial patient recruitment: multilingual voice, SMS, and chat prescreening, medical history collection, and visit scheduling written into the site's CRM or CTMS, with every interaction scored across 20+ QA metrics and physician-audited. 50+ live trials; production for J&J, Medtronic, and Exscientia; $3.8M from Air Street.
Delfa builds AI agents that automate patient recruitment for clinical trials, the single operational bottleneck behind much of trial cost and delay: with 22,000+ drug candidates in the pipeline but only about 5,000 new trials a year, more than a third of the cost comes down to finding, qualifying, and enrolling patients, still a manual funnel of Excel trackers, cold calls, and phone-collected histories.
Delfa replaces that human bottleneck with agents trained on clinical trial documentation and guardrailed accordingly, which speak with patients in any language by phone, SMS, or chat to prescreen for medical eligibility, answer nuanced inclusion and exclusion questions, collect full medical histories (calls regularly run 20 minutes), book visits, and write directly into a site's CRM or CTMS. Quality is enforced heavily: every patient interaction is logged, reviewed, and scored across 20+ QA metrics, physicians audit outputs, and alerts fire in real time when something looks off.
Because patients have opted in to trial contact, the use case is comparatively clean. Delfa already powers 50+ live trials with top site networks and has deployed production AI for J&J, Medtronic, and Exscientia. Reported outcomes include a migraine study site exceeding its enrollment target by 25% while saving 20 recruiter hours at an 11% lead-to-enrolled rate, and a vaccine trial where the agent matched human conversion. The company plans to build an AI-native CRM for patient recruitment on top of the voice wedge. $3.8M from Air Street.
Vendor details
Canonical URL
https://www.delfa.ai
Category
Voice agent
Funding status
$3.8M raised from Air Street Capital (led by Nathan Benaich); London-based, founder Farrand; already speeds patient enrollment for 50+ live clinical trials; deployed production AI for J&J, Medtronic, and Exscientia; works with top site networks including Flourish, Elevate, and Re:Cognition
Company status
independent
Use cases & customers
Primary use cases
Target customers
Deployment options
Integrations
AI agents write directly into a site's CRM or CTMS after each interaction and support native recruitment-progress monitoring from HubSpot; in one documented pattern, Delfa's voice agent completes a pre-screening call and passes the transcript via API to a partner browser agent that logs into the clinical management system and fills out the full screening questionnaire, with exceptions flagged for human review.
Sources & related URLs
Agentic Index coverage score
8.5 / 14 capabilities · 61%
| Integrations & Tool Calling | Full |
|---|---|
|
Agents write directly into a site's CRM or CTMS and support native recruitment monitoring from HubSpot, with API handoff of call transcripts to downstream systems, Air Street and Delfa materials 2026-07-22 |
|
| Workflow Orchestration | Full |
|
Agents fulfill the full recruiter role end to end: prescreen for eligibility, answer inclusion/exclusion questions, collect full medical histories, book visits, and write into the CRM/CTMS, Air Street and Delfa materials 2026-07-22 |
|
| Knowledge Grounding & RAG | Full |
|
Agents are trained on clinical trial documentation and speak about inclusions and exclusions with nuance, grounding screening in each trial's protocol, Air Street materials 2026-07-22 |
|
| Human Oversight & Guardrails | Full |
|
Every interaction is logged, reviewed, and scored across 20+ QA metrics, physicians audit outputs, real-time alerts fire when something looks off, and exceptions are flagged for human review, Air Street and Asteroid materials 2026-07-22 |
|
| Security, Identity & Governance | Partial |
|
Documented HIPAA-grade reliability with full audit trails in the integration workflow, short of named attestations in retrieved materials, Asteroid and Delfa materials 2026-07-22 |
|
| Observability & Auditability | Full |
|
Every patient interaction is logged, reviewed, and scored across 20+ QA metrics with physician audits, real-time alerts, and full audit trails, plus native recruitment monitoring from HubSpot, Air Street and Asteroid materials 2026-07-22 |
|
| Memory & State Persistence | Partial |
|
Agents retain patient histories and progress to prescreen, schedule, and remind the same patients across the recruitment funnel, implying retained per-patient state short of a documented memory layer, Delfa materials 2026-07-22 |
|
| Deployment & Data Residency | Unable to verify |
|
Cloud platform; no self hosting or data residency options documented, Delfa materials 2026-07-22 |
|
| Prebuilt Agents, Templates & Packs | Partial |
|
Agents are configured per trial protocol from clinical documentation, a productized recruiter role adapted per study, short of a self-serve template library, Air Street and Delfa materials 2026-07-22 |
|
| Triggers & Channel Coverage | Full |
|
Agents reach patients in any language by phone, SMS, or chat for outbound outreach and reminders as well as inbound engagement, 24/7, Air Street and Delfa materials 2026-07-22 |
|
| Model Flexibility & Routing | Unable to verify |
|
No customer facing model choice or routing documented, Delfa materials 2026-07-22 |
|
| APIs, SDKs & MCP Extensibility | Partial |
|
Delfa passes call transcripts to downstream agents via API in a documented integration, indicating an API surface, though no public SDK or MCP is documented, Asteroid materials 2026-07-22 |
|
| Testing, Debugging & Optimization | Partial |
|
The 20+ QA metric scoring with physician audit functions as a continuous quality-evaluation loop over agent outputs, short of a documented customer-facing testing or simulation surface, Air Street materials 2026-07-22 |
|
| Browser & Computer Use | Unable to verify |
|
Delfa itself handles the voice conversation; the browser-based CTMS data entry in the documented workflow is performed by a separate partner agent, not Delfa, Asteroid materials 2026-07-22 |
|
The Agentic Index coverage score grades every vendor Full, Partial or Unable to verify against the same 14 buyer facing capabilities, from public evidence only. Each capability links to how all vendors in the index score on it. How this evidence is graded
Pricing
Contact sales
enterprise contract
What is public
The motion is public (enterprise sales to research sites and site networks, ROI framing around enrollment rate and recruiter hours saved); no rates or metering published in retrieved materials.
Variable cost rationale
No billing model published; per-trial or per-enrollment economics are plausible for clinical recruitment but not documented for Delfa.
Sales call required
Yes, required for paid access
Free / trial
Not published
Related vendors
- aiola — Enterprise voice AI for field and frontline teams: the Jargonic ASR…
- Augie — Freight-native AI teammate that owns the full order-to-cash…
- AviaryAI — Outbound-first AI voice agents purpose-built for credit unions,…
- Avoca — The AI front office for home services and the category creator for…
- Broccoli — AI voice agents built for the trades, answering every call for…
- careCycle — AI-native voice platform for Medicare and ACA distribution:…
Alternatives to Delfa
The closest documented capability profiles to Delfa among voice agents tracked by Agentic Index, ordered by similarity on the same 14 point evidence the rankings use. No vendor pays for placement.
- Consio7.5 / 14A lighter documented profile than Delfa
- careCycle8.0 / 14Fuller documented coverage on Security, Identity & GovernanceDelfa vs careCycle →
- Liberate7.0 / 14A lighter documented profile than Delfa
- Casca6.5 / 14A lighter documented profile than Delfa
- EliseAI7.5 / 14Fuller documented coverage on Prebuilt Agents, Templates & Packs
- Phonely8.5 / 14Adds documented Model Flexibility & Routing
Similarity is computed from each vendor's Agentic Index coverage score evidence, axis by axis, not from the totals. How this evidence is graded